Job Description: The Medical Science Liaison (MSL) contributes to company success through:
The MSL is a hybrid function of the affiliate medical manager and the field-based medical scientific liaison with a national as well as a regional scope. The percentage spent on the execution of national activities should be aligned with business priorities and requirements. The MSL is an integral part of the execution of the country medical affairs plan and tactics. The MSL delivers national as well as regional clinical, scientific, and technical educational activities to the health care community, patient organizations, institutions, or payers. The MSL can develop national scientific content for external communication (e.g., slide decks) and supports other functions in the development of material as well as being involved in PRC review. The MSL will support Biogen in advancing biosimilar research programs (clinical research, Real World Data Generation) and investigator-sponsored studies at the national level. The MSL in the Biosimilars Business Unit (BBU) will build long-term peer-to-peer relationships with key medical experts and other stakeholders in therapeutic areas where Biogen biosimilar is developing and/or commercializing products through engagement in national and regional activities. The MSL is responsible for cultivating and maintaining collaborative relationships with members of the medical community to promote company, disease state, and therapeutic awareness, in addition to serving as an advanced technical, scientific, and medical expert in the therapeutic area for the assigned region and medical projects. The MSL is responsible for developing, coordinating, and assuring implementation of Biogen biosimilar corporate, scientific, and clinical strategies working together with key medical experts within academic, clinical, and healthcare organizations. Through scientific exchanges, the MSL will support and/or expand current therapeutic concepts, as well as ensure the safe and effective utilization of Biogen biosimilar product(s). They will also participate in and contribute to projects and initiatives that increase the value and productivity of the broader Medical Affairs team. Principal Accountabilities:
General:
Establish Biogen biosimilars as a leading company committed to patient access and the advancement of biosimilars as a new treatment option. Maintain clinical, scientific, and technical expertise in relevant therapeutic area and other future disease state areas. Have a thorough understanding of the biosimilar development process, biosimilar products, clinical protocols, and related procedures. Collaborate with medical affairs, clinical development, and commercial, serving as a Biogen biosimilar resource to HCPs, large group medical practices, payers, and formulary decision-makers. Participate in/support the training of Biogen biosimilar field and home office employees. Inform proactively other functions on trends in treatment pattern management; can be involved in international activities as business requires. Adhere to corporate SOPs and ensure vigilant compliance with relevant legal and regulatory guidelines governing scientific interactions with physicians and healthcare professionals across all activities, including those related to clinical trials, scientific interactions with internal and external groups, and responses to unsolicited requests for medical/scientific information. Provide medical/clinical teams with feedback and insights from interactions with Key Medical Experts and investigators; inform proactively other functions on trends in treatment pattern management; can be involved in international activities as business requires. Respond to and document unsolicited requests for information on Biogen biosimilar products and clinical programs in full alignment with respective functions (Medical Information, Research). National Scope:
Heighten medical affairs presence and visibility by supporting the medical lead in the execution of national projects and initiatives. Support national requests for dossier review and comment, medical review (PRC), and other unique projects as requested; this can include e.g., advisory board meetings, patient support programs, national satellite symposia, and other educational activities, national digital platforms (e.g., BMA). Regional Scope:
Participate in medical and scientific exchanges with the medical/scientific community including advisory boards in a compliant manner. Depending upon local requirements and regulations on proactive and/or reactive, this may include: Communication/education within the product label (using non-promotional materials). Broad discussion around relevant disease areas. Broader communication which may cover both approved and non-approved products and wider disease area literature.
#J-18808-Ljbffr